The Source • August 2007 • Issue 97

Lessons from a Clinical Trial

by Dawn Yun It’s been almost a year since I was diagnosed with a rare cancer and began a clinical trial. Both seem surreal. I went with a friend to a highly regarded hospital to see Dr. Ryan,* one of the nation’s top authorities for… Read More

From the Executive Director: When Will They Ever Learn? Reflections on the FDA and Cancer Drugs

by Barbara A. Brenner Back in March 2007, two developments at the FDA regarding cancer drugs occurred close on the heels of each other: the issuance of a “black box” warning on drugs approved for treatment of cancer-related anemia and the approval of lapatinib (Tykerb)… Read More

Debu Tripathy: An Oncologist’s Perspective on Cancer Drug Use

by Barbara A. Brenner Debu Tripathy is a professor of internal medicine and the Annette Simmons Distinguished Chair in Breast Cancer Research at the University of Texas Southwestern Medical Center. Through his work in clinical research, he has come to appreciate breast cancer’s complexities, including… Read More